Aleksandr A. Krivopalov

Aleksandr A. Krivopalov

Auto-generated profile, based on publicly available information

Aleksandr A. Krivopalov

Federal State Budgetary Educational Institution «Saint Petersburg Scientific Research Institute of Ear, Throat, Nose and Speech» of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia; Federal State Budgetary Educational Institution of Higher Education «I. I. Mechnikov Northwestern State Medical University» of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Современные проблемы науки и образования (Modern Problems of Science and Education)
Verified
Journal Article
Open access
PSP.A. Shamkina
P.A. Shamkina
AKA.A. Krivopalov
A.A. Krivopalov
SRS.V. Ryazantsev
S.V. Ryazantsev
Natalia A. ShnayderNatalia A. Shnayder
Natalia A. Shnayder
SGS.S. Gaidukov
S.S. Gaidukov
ZSZ.N. Shardanov
Z.N. Shardanov

28 December 2023 in Russian Bulletin of Otorhinolaryngology
Verified
Journal Article
Closed access
AKA.A. Krivopalov
A.A. Krivopalov
NMN.V. Moroz
N.V. Moroz
EBE.G. Belicheva
E.G. Belicheva
MLM.A. Lengina
M.A. Lengina
Актуальность исследования обусловлена наблюдаемым ростом антибиотикорезистентности основных возбудителей хронического риносинусита. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить эффективность фаготерапии в комплексном лечении пациентов с обострениями хронического риносинусита. МАТЕРИАЛ И МЕТОДЫ В исследование включены 55 пациентов с верифицированным диагнозом хронического риносинусита и наличием в анамнезе периодических обострений в течение года, госпитализированных в СПб ГБУЗ «Городская больница Святой преподобномученицы Елизаветы» с января 2022 г. по февраль 2023 г. В зависимости от получаемого противомикробного лечения пациенты распределены на группы. Всем пациентам выполнены пункции верхнечелюстных пазух. Пациентам 1-й группы, получающим антибиотикотерапию, пазухи промывали раствором натрия хлорида 0,9%, при лечении пациентов 2-й группы использовали бактериофаг. Для определения чувствительности к антибиотикам и бактериофагу использовали материал, полученный при первой пункции верхнечелюстных пазух. РЕЗУЛЬТАТЫ Средняя продолжительность лечения до положительного исхода у пациентов, получавших антибиотикотерапию, составила 8,0±1,59 дня, тогда как у пациентов, получавших фаготерапию, 7,69±1,35 дня (p=0,3008). Статистически значимых различий между группами в средней продолжительности лечения до достижения благоприятного исхода не было. ЗАКЛЮЧЕНИЕ Высокая эффективность фаготерапии в сравнении с антибиотикотерапией, отсутствие ее влияния на рост антибиотикорезистентности позволяют рекомендовать применение бактериофагов в лечении хронического риносинусита.

1 January 2022 in Russian Otorhinolaryngology
Verified
Journal Article
Closed access
AKA. A. Krivopalov
A. A. Krivopalov
NMN. V. Moroz
N. V. Moroz
SAS. A. Artyushkin
S. A. Artyushkin
PSP. A. Shamkina
P. A. Shamkina
GZG. P. Zakharova
G. P. Zakharova
Objective. To summarize data on the epidemiology of chronic rhinosinusitis (CRS) with an emphasis on prevalence and risk factors. Materials and methods. The analysis of English- and Russian-language publications using databases: PubMed, Russian Science Citation Index, Springer, Scopus, Scientific Research, Crossref, eLibrary. The search depth is 10 years (2012–2022). The paper presents data from original epidemiological studies, reflects differences in estimates of the prevalence of the disease depending on the research method, sample characteristics, predisposing environmental conditions. Results. The use of symptomatology and objective diagnostic criteria makes it possible to identify the prevalence of CRS in more than 10% of the population. When using both methods, the true prevalence of CRS is about 5%. Differences in the prevalence of CRS associated with concomitant living conditions and the general condition of patients indicate the presence of risk factors, such as modifiable: smoking, air pollution, socioeconomic, comorbid diseases, as well as unmodified: hereditary, demographic (gender, race, age). Conclusion. During the follow-up period, along with the introduction of new treatment methods, the prevalence of CRS in Russia and the world has been maintained, which requires improving the organizational and methodological approach to the prevention, diagnosis, and treatment of this disease. The expansion of data on the epidemiological patterns of CRS makes it possible to optimally identify the disease process for each patient, thereby contributing to an increase in the effectiveness of treatment at the general social level.

1 December 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
PSP. A. Shamkina
P. A. Shamkina
AKA. A. Krivopalov
A. A. Krivopalov
PPP. I. Panchenko
P. I. Panchenko
SRSergey Ryazantsev
Sergey Ryazantsev
The overuse and inappropriate use of systemic antibiotics is the most serious cause of problems associated with the increasing resistance of bacterial pathogens. What served as the basis for WHO to call the XXI century “The era of antibiotic resistance”. The wide spread of resistant strains of microorganisms, the growth of severe and complicated forms of diseases leads to an increase in the frequency of unfavorable treatment outcomes. In the Russian Federation, an increase in the incidence of acute rhinosinusitis from 4.6 to 12.7 cases per 1000 population has been noted in the last decade. The incidence of acute rhinosinusitis in Europe is recorded in 6.4 ± 3.6 of all cases of visits to primary care physicians. Up to 38% of outpatients in the ENT profile suffer from various forms of otitis media, including up to 30% of acute otitis media. The most important way to overcome the global problem of antibiotic resistance, along with the delayed use of systemic antibacterial drugs initiated by the world medical community, is to switch to the active use of topical drugs with antimicrobial activity. The article provides an overview of the data of domestic and foreign literature on the properties of a topical antibacterial drug with the active ingredient hydroxymethylquinoxaline dioxide. The results of experimental work and clinical studies, proving the high efficacy and safety of the drug in the complex treatment of bacterial infections of the upper respiratory tract, have been analyzed.

1 January 2019 in Russian Otorhinolaryngology
Verified
Journal Article
Closed access
YYYu. K. Yanov
Yu. K. Yanov
AKA. A. Krivopalov
A. A. Krivopalov
NTN. A. Tuzikov
N. A. Tuzikov
NSN. A. Shnaider
N. A. Shnaider
RNRegina F. Nasyrova
Regina F. Nasyrova
SHSaint Petersburg Botkin Saint Petersburg Infectious Diseases Hospital
Saint Petersburg Botkin Saint Petersburg Infectious Diseases Hospital
The lecture is devoted to the content and assessment of the quality of medical care in general and specialized otorhinolaryngological care in particular. The lecture provides the basic concepts of medical care in general, its main types and forms of provision. The authors define the concept of specialized otorhinolaryngological care from the viewpoint of regulatory documents of the Ministry of Healthcare of Russia and current regulatory documents, its role in the system of medical care of our country, providing the routing of the patients at all its stages. The lecture presents the approaches to assessing the quality of specialized otorhinolaryngological care. The authors determine the concept of mistake and defect, their main types and causes, their effect on the safety and efficacy of specialized otorhinolaryngological care. The work covers the legal aspects of assessment of provided otorhinolaryngological care quality, pointing out the important problem of the absence of a single approach to such assessment in otorhinolaryngology. The authors substantiate the necessity of original and multipurpose system of expert assessment of quality of provided otorhinolaryngological care based on automatic quality evaluation technology as a prototype. The next work will be devoted to its peculiarities as well as to the problems existing in clinical otorhinolaryngology.

1 December 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. A. Krivopalov
A. A. Krivopalov
PSP. A. Shamkina
P. A. Shamkina
JSJu. E. Stepanova
Ju. E. Stepanova
ЕКЕ. Е. Корень
Е. Е. Корень
TGT. V. Gotovyakhina
T. V. Gotovyakhina
Introduction. Today the high prevalence of benign vocal fold lesions is shown (up to 55-70%). The possibilities of surgical management of this pathology are very extensive. Laser technologies are becoming more and more popular among high-tech treatment methods. However the comprehensive postoperative management of these patients is equally important.The aim of the study was to assess the features of the postoperative period in patients undergoing the endolaryngeal surgery using a semiconductor laser with a wavelength of 445 nm.Material and methods. On the basis of Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech from February to June 2021 20 patients with benign vocal fold lesions 6 women and 14 men from 24 to 67 years old were examined and treated. All the patients underwent endolaryngeal surgery with direct microlaryngoscopy using a new semiconductor 445 nm laser in an inert gas atmosphere (intraoperative helium supply). After surgical treatment, the patients observed vocal rest, received antiinflammatory, antibacterial therapy, inhalations, as well as the drug Homeovox® according to the standard scheme.Conclusion. Endolaryngeal surgery with the removing of benign vocal fold lesions using a semiconductor laser with a wavelength of 445 nm has been proven to be safe and effective. According to the results of video laryngostroboscopy, acoustic analysis of the voice (the questionnaire “Voice handicap index-30”) it was noted that the laryngeal functions were restored in a short time. The inclusion of Homeovox® in the complex postoperative treatment had a favorable effect on the restoration of the phonatory function.